Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing
The Pharmacogenomics Journal, Published online: 04 November 2023; doi:10.1038/s41397-023-00320-zPharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 4, 2023 Category: Drugs & Pharmacology Authors: Jai N. Patel Myra Robinson Sarah A. Morris Elizabeth Jandrisevits Karine Eboli Lopes Alicia Hamilton Nury Steuerwald Lawrence J. Druhan Belinda Avalos Edward Copelan Nilanjan Ghosh Michael R. Grunwald Source Type: research
British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis
The Pharmacogenomics Journal, Published online: 01 November 2023; doi:10.1038/s41397-023-00317-8British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 1, 2023 Category: Drugs & Pharmacology Authors: Emma F. Magavern Faiza Durrani Mehru Raza Robin Lerner Mohammed Riadul Islam Megan Clinch Mark J. Caulfield Source Type: research
Using ChatGPT to predict the future of personalized medicine
The Pharmacogenomics Journal, Published online: 19 September 2023; doi:10.1038/s41397-023-00316-9Using ChatGPT to predict the future of personalized medicine (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 19, 2023 Category: Drugs & Pharmacology Authors: George P. Patrinos Negar Sarhangi Behnaz Sarrami Nazli Khodayari Bagher Larijani Mandana Hasanzad Source Type: research
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial
The Pharmacogenomics Journal, Published online: 09 September 2023; doi:10.1038/s41397-023-00315-wThe INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - September 9, 2023 Category: Drugs & Pharmacology Authors: Michael T. Eadon Marc B. Rosenman Pengyue Zhang Cathy R. Fulton John T. Callaghan Ann M. Holmes Kenneth D. Levy Samir K. Gupta David M. Haas Raj Vuppalanchi Eric A. Benson Rolf P. Kreutz Emma M. Tillman Tyler Shugg Rebecca C. Pierson Brandon T. Gufford Vi Source Type: research
Assessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications
The Pharmacogenomics Journal, Published online: 26 August 2023; doi:10.1038/s41397-023-00313-yAssessment of clinically actionable pharmacogenetic markers to stratify anti-seizure medications (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - August 26, 2023 Category: Drugs & Pharmacology Authors: Debleena Guin Yasha Hasija Ritushree Kukreti Source Type: research
Genome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank
The Pharmacogenomics Journal, Published online: 16 August 2023; doi:10.1038/s41397-023-00314-xGenome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - August 16, 2023 Category: Drugs & Pharmacology Authors: Song Li Geert Poelmans Regina L. M. van Boekel Marieke J. H. Coenen Source Type: research
HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients
The Pharmacogenomics Journal, Published online: 17 July 2023; doi:10.1038/s41397-023-00312-zHLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - July 17, 2023 Category: Drugs & Pharmacology Authors: Fumiko Shimoda Takeo Naito Yoichi Kakuta Yosuke Kawai Katsushi Tokunaga Hatsue Ishibashi-Ueda Tsutomu Tomita Michio Noguchi Ayako Takahashi Yu-ichi Goto Sumiko Yoshida Kotaro Hattori Ryo Matsumura Aritoshi Iida Yutaka Maruoka Hiroyuki Gatanaga Masaya Sugi Source Type: research
Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
The Pharmacogenomics Journal, Published online: 25 May 2023; doi:10.1038/s41397-023-00311-0Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 25, 2023 Category: Drugs & Pharmacology Authors: Stefania Cheli Diego Savino Annalisa De Silvestri Lorenzo Norsa Naire Sansotta Francesca Penagini Dario Dilillo Roberto Panceri Dario Cattaneo Emilio Clementi Giovanna Zuin Source Type: research
SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort
The Pharmacogenomics Journal, Published online: 23 May 2023; doi:10.1038/s41397-023-00307-wSLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 23, 2023 Category: Drugs & Pharmacology Authors: Emma F. Magavern David A. van Heel Damian Smedley Mark J. Caulfield Source Type: research
Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis
The Pharmacogenomics Journal, Published online: 06 May 2023; doi:10.1038/s41397-023-00308-9Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 6, 2023 Category: Drugs & Pharmacology Authors: Young Ho Lee Gwan Gyu Song Source Type: research
Knowledge and attitudes of medical and pharmacy students about pharmacogenomics: a systematic review and meta-analysis
The Pharmacogenomics Journal, Published online: 04 May 2023; doi:10.1038/s41397-023-00306-xKnowledge and attitudes of medical and pharmacy students about pharmacogenomics: a systematic review and meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 4, 2023 Category: Drugs & Pharmacology Authors: Chen Li Xiaona Su Qidi Sun Yi Huang Source Type: research
DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?
The Pharmacogenomics Journal, Published online: 03 May 2023; doi:10.1038/s41397-023-00303-0DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 3, 2023 Category: Drugs & Pharmacology Authors: Tekla Harju Anri Hurme-Niiranen Maria Suo-Palosaari Stine Nygaard Nielsen Reetta Hinttala Kjeld Schmiegelow Johanna Uusimaa Arja Harila Riitta Niinim äki Source Type: research
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study
The Pharmacogenomics Journal, Published online: 27 April 2023; doi:10.1038/s41397-023-00305-yPolygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 27, 2023 Category: Drugs & Pharmacology Authors: Kazunari Yoshida Victoria S. Marshe Samar S. M. Elsheikh Malgorzata Maciukiewicz Arun K. Tiwari Eva J. Brandl Jeffrey A. Lieberman Herbert Y. Meltzer James L. Kennedy Daniel J. M üller Source Type: research
One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
The Pharmacogenomics Journal, Published online: 04 April 2023; doi:10.1038/s41397-023-00304-zOne year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 4, 2023 Category: Drugs & Pharmacology Authors: Stefania Cheli Diego Savino Annalisa De Silvestri Lorenzo Norsa Naire Sansotta Francesca Penagini Dario Dilillo Roberto Panceri Dario Cattaneo Emilio Clementi Giovanna Zuin Source Type: research
Non-steroidal anti-inflammatory drug target gene associations with major depressive disorders: a Mendelian randomisation study integrating GWAS, eQTL and mQTL Data
The Pharmacogenomics Journal, Published online: 25 March 2023; doi:10.1038/s41397-023-00302-1Non-steroidal anti-inflammatory drug target gene associations with major depressive disorders: a Mendelian randomisation study integrating GWAS, eQTL and mQTL Data (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - March 25, 2023 Category: Drugs & Pharmacology Authors: Qian He Kevin Chun Hei Wu Adam N. Bennett Beifang Fan Jundong Liu Ruixuan Huang Alice P. S. Kong Xiaoyu Tian Man Ki Maggie Kwok Kei Hang Katie Chan Source Type: research
